申请人:Arrington Mark P.
公开号:US20090099175A1
公开(公告)日:2009-04-16
The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
本发明涉及某些具有PDE10抑制剂作用的茚啉化合物,包括含有这些化合物的制药组合物和制备这些化合物的方法。该发明还涉及通过PDE10酶介导的疾病的治疗方法,例如肥胖症、非胰岛素依赖性糖尿病、精神分裂症、双相情感障碍、强迫症等。